Target intelligence / Profile preview

Exosomal microRNA (exo-miRNA)

Target
exo-miRNA
Molecular classification
Non-coding RNA, MicroRNA family
01

Overview

Exosomal microRNAs (exo-miRNAs) are a class of small, non-coding RNA molecules typically 19-25 nucleotides in length that are packaged into exosomes for intercellular communication (Valadi et al., 2007, Nature Cell Biology). These molecules are secreted by various cell types into the extracellular environment and are protected from enzymatic degradation by the lipid bilayer of the exosome (Zhang et al., 2015, Nature). Upon uptake by recipient cells, exo-miRNAs function as key regulators of gene expression by binding to complementary sequences on target messenger RNAs (mRNAs), leading to translational repression or mRNA cleavage (NIH/NCBI). In the context of disease, exo-miRNAs are frequently dysregulated and contribute to the pathogenesis of cancer, cardiovascular disorders, and neurodegenerative conditions by modulating the microenvironment and promoting processes like angiogenesis or immune evasion (PubMed). As therapeutic targets, they can be modulated using antisense oligonucleotides to inhibit oncogenic miRNAs or supplemented with miRNA mimics to restore tumor-suppressive functions (ClinicalTrials.gov). Furthermore, their stability in biofluids makes them highly attractive candidates for non-invasive liquid biopsy biomarkers in precision medicine. The development of exosome-based delivery systems for these miRNAs represents a significant frontier in targeted drug delivery and regenerative medicine.

Other names
Exosome-derived microRNAExosomal miRNAExtracellular vesicle-contained microRNAexo-miR
02

Mechanism of action

Exosomal microRNAs act by binding to the 3' untranslated region (UTR) of target mRNAs within recipient cells, leading to mRNA degradation or translational inhibition through the RNA-induced silencing complex (RISC) (NIH/NCBI).

03

Biological functions

Intercellular communicationPost-transcriptional gene regulationSignal transductionGene silencing
04

Disease associations

CancerCardiovascular diseaseNeurodegenerative diseaseInflammationMetabolic disorder
05

Safety considerations

Off-target effectsImmunogenicity of delivery vehiclesSystemic toxicityTargeting specificity challenges
06

Interacting drugs

Cobomarsen

6 more in the full profile.

07

Biomarkers

Exosomal miR-21Exosomal miR-155Exosomal miR-122Exosomal miR-141

Beyond the preview

Go deeper on Exosomal microRNA (exo-miRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exosomal microRNA (exo-miRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call